
2023-2029 Global Nervous System Medications Industry Research & Trends Analysis Report
Get latest Market Research Reports on Nervous System Medications. Industry analysis and Market Report on Nervous System Medications is a syndicated market report, published as Global Nervous System Medications Market Research Report . It is complete Research Study and Industry Analysis of Nervous System Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to the research report, the global market for Nervous System Medications should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Nervous System Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Nervous System Medications market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Anesthetic segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital Pharmacy has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Nervous System Medications include Pfizer, Teva, Novartis, AstraZeneca, Takeda, Johnson & Johnson, EliLilly, Otsuka and Merck, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Nervous System Medications. Key Takeaways and Highlights
(1) Global Nervous System Medications market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Nervous System Medications market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Nervous System Medications market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Nervous System Medications segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Nervous System Medications segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Nervous System Medications, capacity, production and trends.
(7) Nervous System Medications industry supply chain, upstream, midstream and downstream analysis.
Regional Breakdown: Analyzing Market Segments by Geography
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Segmenting by Type: Comprehensive Coverage and Analysis
Anesthetic
Painkiller
Psychostimulants
Antiepileptic Drugs
Anti-Parkinson Drugs
Others
Application-Based Segmentation: Unlocking Market Opportunities
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
In the Spotlight: A Closer Look at Market Players
Pfizer
Teva
Novartis
AstraZeneca
Takeda
Johnson & Johnson
EliLilly
Otsuka
Merck
Yangtze River Pharmaceutical
Humanwell Healthcare
CSPC-NBP Pharmaceutical
Nhwa Pharmaceutical
Qilu Pharma
1 Market Overview
1.1 Nervous System Medications Definition
1.2 Global Nervous System Medications Market Size and Forecast
1.2.1 By Revenue, Global Nervous System Medications Market Size, 2018-2029
1.2.2 By Sales Volume, Global Nervous System Medications Market Size, 2018-2029
1.2.3 Global Nervous System Medications Price Trend, 2018-2029
1.3 China Nervous System Medications Market Size and Forecast
1.3.1 By Revenue, China Nervous System Medications Market Size, 2018-2029
1.3.2 By Sales Volume, China Nervous System Medications Market Size, 2018-2029
1.3.3 China Nervous System Medications Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Nervous System Medications Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Nervous System Medications Share in Global Market, 2018-2029
1.4.3 Nervous System Medications Market Size: China VS Global, 2018-2029
1.5 Nervous System Medications Market Dynamics
1.5.1 Nervous System Medications Market Drivers
1.5.2 Nervous System Medications Market Restraints
1.5.3 Nervous System Medications Industry Trends
1.5.4 Nervous System Medications Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Nervous System Medications Revenue by Company, 2018-2023
2.2 Global Nervous System Medications Sales Volume by Company, 2018-2023
2.3 Global Nervous System Medications Price by Company, 2018-2023
2.4 Global Nervous System Medications Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Nervous System Medications Concentration Ratio
2.6 Global Nervous System Medications Mergers & Acquisitions, Expansion Plans
2.7 Global Nervous System Medications Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Nervous System Medications Revenue by Company, 2018-2023
3.2 China Nervous System Medications Sales Volume by Company, 2018-2023
3.3 China Nervous System Medications Nervous System Medications Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Nervous System Medications Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Nervous System Medications Domestic VS Export
3.6 China Market, Nervous System Medications Import & Export
3.6.1 China Market, Nervous System Medications Import & Export, 2018-2029
3.6.2 China Nervous System Medications Import & Export Trends
3.6.3 Main Sources of China Nervous System Medications Import
3.6.4 Export Destination of China Nervous System Medications
4 Nervous System Medications Production by Region
4.1 Global Nervous System Medications Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Nervous System Medications Manufacturers
4.3 Global Major Manufacturers, Nervous System Medications Capacity Expansion and Future Plans
4.4 Global Nervous System Medications Capacity by Region
4.5 Global Nervous System Medications Production by Region
4.5.1 Global Nervous System Medications Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Nervous System Medications Production by Region, 2018-2023
4.5.3 Global Nervous System Medications Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Nervous System Medications Industry Chain
5.2 Nervous System Medications Upstream Analysis
5.2.1 Nervous System Medications Core Raw Materials
5.2.2 Main Manufacturers of Nervous System Medications Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Nervous System Medications Production Mode
5.6 Nervous System Medications Procurement Model
5.7 Nervous System Medications Industry Sales Model and Sales Channels
5.7.1 Nervous System Medications Sales Model
5.7.2 Nervous System Medications Typical Distributors
6 Sights by Type
6.1 Nervous System Medications Classification
6.1.1 Anesthetic
6.1.2 Painkiller
6.1.3 Psychostimulants
6.1.4 Antiepileptic Drugs
6.1.5 Anti-Parkinson Drugs
6.1.6 Others
6.2 By Type, Global Nervous System Medications Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Nervous System Medications Revenue, 2018-2029
6.4 By Type, Global Nervous System Medications Sales Volume, 2018-2029
6.5 By Type, Global Nervous System Medications Price, 2018-2029
7 Sights by Application
7.1 Nervous System Medications Segment by Application
7.1.1 Hospital Pharmacy
7.1.2 Retail Pharmacy
7.1.3 Online Pharmacy
7.2 By Application, Global Nervous System Medications Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Nervous System Medications Revenue, 2018-2029
7.4 By Application, Global Nervous System Medications Sales Volume, 2018-2029
7.5 By Application, Global Nervous System Medications Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Nervous System Medications Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Nervous System Medications Revenue, 2018-2029
8.3 By Region, Global Nervous System Medications Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Nervous System Medications Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Nervous System Medications Market Size Market Share
8.5 Europe
8.5.1 Europe Nervous System Medications Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Nervous System Medications Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Nervous System Medications Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Nervous System Medications Market Size Market Share
8.7 South America
8.7.1 South America Nervous System Medications Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Nervous System Medications Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Nervous System Medications Market Size & CAGR,2018 VS 2022 VS 2029
9.2 By Country, Global Nervous System Medications Revenue, 2018-2029
9.3 By Country, Global Nervous System Medications Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Nervous System Medications Market Size, 2018-2029
9.4.2 By Company, U.S. Nervous System Medications Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Nervous System Medications Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Nervous System Medications Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Nervous System Medications Market Size, 2018-2029
9.5.2 By Company, Europe Nervous System Medications Sales Volume Market Share, 2022
9.5.3 By Type, Europe Nervous System Medications Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Nervous System Medications Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Nervous System Medications Market Size, 2018-2029
9.6.2 By Company, China Nervous System Medications Sales Volume Market Share, 2022
9.6.3 By Type, China Nervous System Medications Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Nervous System Medications Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Nervous System Medications Market Size, 2018-2029
9.7.2 By Company, Japan Nervous System Medications Sales Volume Market Share, 2022
9.7.3 By Type, Japan Nervous System Medications Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Nervous System Medications Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Nervous System Medications Market Size, 2018-2029
9.8.2 By Company, South Korea Nervous System Medications Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Nervous System Medications Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Nervous System Medications Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Nervous System Medications Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Nervous System Medications Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Nervous System Medications Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Nervous System Medications Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Nervous System Medications Market Size, 2018-2029
9.10.2 By Company, India Nervous System Medications Sales Volume Market Share, 2022
9.10.3 By Type, India Nervous System Medications Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Nervous System Medications Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Nervous System Medications Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Nervous System Medications Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Nervous System Medications Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Nervous System Medications Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Pfizer
10.1.1 Pfizer Company Information, Head Office, Market Area and Industry Position
10.1.2 Pfizer Nervous System Medications Models, Specifications and Application
10.1.3 Pfizer Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Pfizer Company Profile and Main Business
10.1.5 Pfizer Recent Developments
10.2 Teva
10.2.1 Teva Company Information, Head Office, Market Area and Industry Position
10.2.2 Teva Nervous System Medications Models, Specifications and Application
10.2.3 Teva Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Teva Company Profile and Main Business
10.2.5 Teva Recent Developments
10.3 Novartis
10.3.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.3.2 Novartis Nervous System Medications Models, Specifications and Application
10.3.3 Novartis Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Novartis Company Profile and Main Business
10.3.5 Novartis Recent Developments
10.4 AstraZeneca
10.4.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position
10.4.2 AstraZeneca Nervous System Medications Models, Specifications and Application
10.4.3 AstraZeneca Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 AstraZeneca Company Profile and Main Business
10.4.5 AstraZeneca Recent Developments
10.5 Takeda
10.5.1 Takeda Company Information, Head Office, Market Area and Industry Position
10.5.2 Takeda Nervous System Medications Models, Specifications and Application
10.5.3 Takeda Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Takeda Company Profile and Main Business
10.5.5 Takeda Recent Developments
10.6 Johnson & Johnson
10.6.1 Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
10.6.2 Johnson & Johnson Nervous System Medications Models, Specifications and Application
10.6.3 Johnson & Johnson Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Johnson & Johnson Company Profile and Main Business
10.6.5 Johnson & Johnson Recent Developments
10.7 EliLilly
10.7.1 EliLilly Company Information, Head Office, Market Area and Industry Position
10.7.2 EliLilly Nervous System Medications Models, Specifications and Application
10.7.3 EliLilly Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 EliLilly Company Profile and Main Business
10.7.5 EliLilly Recent Developments
10.8 Otsuka
10.8.1 Otsuka Company Information, Head Office, Market Area and Industry Position
10.8.2 Otsuka Nervous System Medications Models, Specifications and Application
10.8.3 Otsuka Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Otsuka Company Profile and Main Business
10.8.5 Otsuka Recent Developments
10.9 Merck
10.9.1 Merck Company Information, Head Office, Market Area and Industry Position
10.9.2 Merck Nervous System Medications Models, Specifications and Application
10.9.3 Merck Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Merck Company Profile and Main Business
10.9.5 Merck Recent Developments
10.10 Yangtze River Pharmaceutical
10.10.1 Yangtze River Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.10.2 Yangtze River Pharmaceutical Nervous System Medications Models, Specifications and Application
10.10.3 Yangtze River Pharmaceutical Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Yangtze River Pharmaceutical Company Profile and Main Business
10.10.5 Yangtze River Pharmaceutical Recent Developments
10.11 Humanwell Healthcare
10.11.1 Humanwell Healthcare Company Information, Head Office, Market Area and Industry Position
10.11.2 Humanwell Healthcare Nervous System Medications Models, Specifications and Application
10.11.3 Humanwell Healthcare Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Humanwell Healthcare Company Profile and Main Business
10.11.5 Humanwell Healthcare Recent Developments
10.12 CSPC-NBP Pharmaceutical
10.12.1 CSPC-NBP Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.12.2 CSPC-NBP Pharmaceutical Nervous System Medications Models, Specifications and Application
10.12.3 CSPC-NBP Pharmaceutical Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 CSPC-NBP Pharmaceutical Company Profile and Main Business
10.12.5 CSPC-NBP Pharmaceutical Recent Developments
10.13 Nhwa Pharmaceutical
10.13.1 Nhwa Pharmaceutical Company Information, Head Office, Market Area and Industry Position
10.13.2 Nhwa Pharmaceutical Nervous System Medications Models, Specifications and Application
10.13.3 Nhwa Pharmaceutical Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Nhwa Pharmaceutical Company Profile and Main Business
10.13.5 Nhwa Pharmaceutical Recent Developments
10.14 Qilu Pharma
10.14.1 Qilu Pharma Company Information, Head Office, Market Area and Industry Position
10.14.2 Qilu Pharma Nervous System Medications Models, Specifications and Application
10.14.3 Qilu Pharma Nervous System Medications Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.14.4 Qilu Pharma Company Profile and Main Business
10.14.5 Qilu Pharma Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Nervous System Medications Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Nervous System Medications Market Restraints
Table 3. Nervous System Medications Market Trends
Table 4. Nervous System Medications Industry Policy
Table 5. Global Nervous System Medications Revenue by Company, 2018-2023, US$ million
Table 6. Global Nervous System Medications Revenue Market Share by Company, 2018-2023
Table 7. Global Nervous System Medications Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Nervous System Medications Sales Volume Market Share by Company, 2018-2023
Table 9. Global Nervous System Medications Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Nervous System Medications Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Nervous System Medications Mergers & Acquisitions, Expansion Plans
Table 12. Global Nervous System Medications Manufacturers Product Type
Table 13. China Nervous System Medications Revenue by Company, 2018-2023, US$ million
Table 14. China Nervous System Medications Revenue Market Share by Company, 2018-2023
Table 15. China Nervous System Medications Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Nervous System Medications Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Nervous System Medications Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Nervous System Medications Import & Export Trends
Table 19. Main Sources of China Nervous System Medications Import
Table 20. Export Destination of China Nervous System Medications
Table 21. Global Headquarters and Manufacturing Base of Nervous System Medications Manufacturers
Table 22. Global Major Manufacturers, Nervous System Medications Capacity Expansion and Future Plans
Table 23. Global Nervous System Medications Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Nervous System Medications Production by Region, 2018-2023, (K Units)
Table 25. Global Nervous System Medications Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Nervous System Medications Upstream (Raw Materials)
Table 27. Global Nervous System Medications Typical Customers
Table 28. Nervous System Medications Typical Distributors
Table 29. By Type, Global Nervous System Medications Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Nervous System Medications Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Nervous System Medications Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Nervous System Medications Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Nervous System Medications Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Nervous System Medications Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Nervous System Medications Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Nervous System Medications Revenue Market Share, 2018-2029
Table 37. By Country, Global Nervous System Medications Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Nervous System Medications Sales Volume Market Share, 2018-2029
Table 39. Pfizer Company Information, Head Office, Market Area and Industry Position
Table 40. Pfizer Nervous System Medications Models, Specifications and Application
Table 41. Pfizer Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Pfizer Company Profile and Main Business
Table 43. Pfizer Recent Developments
Table 44. Teva Company Information, Head Office, Market Area and Industry Position
Table 45. Teva Nervous System Medications Models, Specifications and Application
Table 46. Teva Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Teva Company Profile and Main Business
Table 48. Teva Recent Developments
Table 49. Novartis Company Information, Head Office, Market Area and Industry Position
Table 50. Novartis Nervous System Medications Models, Specifications and Application
Table 51. Novartis Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Novartis Company Profile and Main Business
Table 53. Novartis Recent Developments
Table 54. AstraZeneca Company Information, Head Office, Market Area and Industry Position
Table 55. AstraZeneca Nervous System Medications Models, Specifications and Application
Table 56. AstraZeneca Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. AstraZeneca Company Profile and Main Business
Table 58. AstraZeneca Recent Developments
Table 59. Takeda Company Information, Head Office, Market Area and Industry Position
Table 60. Takeda Nervous System Medications Models, Specifications and Application
Table 61. Takeda Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Takeda Company Profile and Main Business
Table 63. Takeda Recent Developments
Table 64. Johnson & Johnson Company Information, Head Office, Market Area and Industry Position
Table 65. Johnson & Johnson Nervous System Medications Models, Specifications and Application
Table 66. Johnson & Johnson Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Johnson & Johnson Company Profile and Main Business
Table 68. Johnson & Johnson Recent Developments
Table 69. EliLilly Company Information, Head Office, Market Area and Industry Position
Table 70. EliLilly Nervous System Medications Models, Specifications and Application
Table 71. EliLilly Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. EliLilly Company Profile and Main Business
Table 73. EliLilly Recent Developments
Table 74. Otsuka Company Information, Head Office, Market Area and Industry Position
Table 75. Otsuka Nervous System Medications Models, Specifications and Application
Table 76. Otsuka Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Otsuka Company Profile and Main Business
Table 78. Otsuka Recent Developments
Table 79. Merck Company Information, Head Office, Market Area and Industry Position
Table 80. Merck Nervous System Medications Models, Specifications and Application
Table 81. Merck Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Merck Company Profile and Main Business
Table 83. Merck Recent Developments
Table 84. Yangtze River Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 85. Yangtze River Pharmaceutical Nervous System Medications Models, Specifications and Application
Table 86. Yangtze River Pharmaceutical Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Yangtze River Pharmaceutical Company Profile and Main Business
Table 88. Yangtze River Pharmaceutical Recent Developments
Table 89. Humanwell Healthcare Company Information, Head Office, Market Area and Industry Position
Table 90. Humanwell Healthcare Nervous System Medications Models, Specifications and Application
Table 91. Humanwell Healthcare Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Humanwell Healthcare Company Profile and Main Business
Table 93. Humanwell Healthcare Recent Developments
Table 94. CSPC-NBP Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 95. CSPC-NBP Pharmaceutical Nervous System Medications Models, Specifications and Application
Table 96. CSPC-NBP Pharmaceutical Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. CSPC-NBP Pharmaceutical Company Profile and Main Business
Table 98. CSPC-NBP Pharmaceutical Recent Developments
Table 99. Nhwa Pharmaceutical Company Information, Head Office, Market Area and Industry Position
Table 100. Nhwa Pharmaceutical Nervous System Medications Models, Specifications and Application
Table 101. Nhwa Pharmaceutical Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. Nhwa Pharmaceutical Company Profile and Main Business
Table 103. Nhwa Pharmaceutical Recent Developments
Table 104. Qilu Pharma Company Information, Head Office, Market Area and Industry Position
Table 105. Qilu Pharma Nervous System Medications Models, Specifications and Application
Table 106. Qilu Pharma Nervous System Medications Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 107. Qilu Pharma Company Profile and Main Business
Table 108. Qilu Pharma Recent Developments
List of Figure
Figure 1. Nervous System Medications Picture
Figure 2. By Revenue, Global Nervous System Medications Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Nervous System Medications Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Nervous System Medications Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Nervous System Medications Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Nervous System Medications Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Nervous System Medications Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Nervous System Medications Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Nervous System Medications Share of Global Market, 2018-2029
Figure 10. Global Nervous System Medications Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Nervous System Medications Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Nervous System Medications Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Nervous System Medications Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Nervous System Medications Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Nervous System Medications Domestic VS Export, 2022
Figure 16. Global Nervous System Medications Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Nervous System Medications Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Nervous System Medications Production Market Share & Forecast by Region, 2018-2029
Figure 19. Nervous System Medications Industry Chain
Figure 20. Nervous System Medications Procurement Model
Figure 21. Nervous System Medications Sales Model
Figure 22. Nervous System Medications Sales Channels, Direct Sales and Distribution
Figure 23. Anesthetic
Figure 24. Painkiller
Figure 25. Psychostimulants
Figure 26. Antiepileptic Drugs
Figure 27. Anti-Parkinson Drugs
Figure 28. Others
Figure 29. By Type, Global Nervous System Medications Revenue, 2018-2029, US$ Million
Figure 30. By Type, Global Nervous System Medications Revenue Market Share, 2018-2029
Figure 31. By Type, Global Nervous System Medications Sales Volume, 2018-2029, (K Units)
Figure 32. By Type, Global Nervous System Medications Sales Volume Market Share, 2018-2029
Figure 33. By Type, Global Nervous System Medications Price, 2018-2029, (US$/Unit)
Figure 34. Hospital Pharmacy
Figure 35. Retail Pharmacy
Figure 36. Online Pharmacy
Figure 37. By Application, Global Nervous System Medications Revenue, 2018-2029, US$ Million
Figure 38. By Application, Global Nervous System Medications Revenue Market Share, 2018-2029
Figure 39. By Application, Global Nervous System Medications Sales Volume, 2018-2029, (K Units)
Figure 40. By Application, Global Nervous System Medications Sales Volume Market Share, 2018-2029
Figure 41. By Application, Global Nervous System Medications Price, 2018-2029, (US$/Unit)
Figure 42. By Region, Global Nervous System Medications Revenue Market Share, 2018-2029
Figure 43. By Region, Global Nervous System Medications Sales Volume Market Share, 2018-2029
Figure 44. North America Nervous System Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 45. By Country, North America Nervous System Medications Revenue Market Share, 2022
Figure 46. Europe Nervous System Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 47. By Country, Europe Nervous System Medications Revenue Market Share, 2022
Figure 48. Asia Pacific Nervous System Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 49. By Country/Region, Asia Pacific Nervous System Medications Revenue Market Share, 2022
Figure 50. South America Nervous System Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 51. By Country, South America Nervous System Medications Revenue Market Share, 2022
Figure 52. Middle East & Africa Nervous System Medications Revenue & Forecasts, 2018-2029, US$ Million
Figure 53. U.S. Nervous System Medications Sales Volume, 2018-2029, (K Units)
Figure 54. By Company, U.S. Nervous System Medications Market Share, 2022
Figure 55. By Type, U.S. Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 56. By Application, U.S. Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 57. Europe Nervous System Medications Sales Volume, 2018-2029, (K Units)
Figure 58. By Company, Europe Nervous System Medications Market Share, 2022
Figure 59. By Type, Europe Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 60. By Application, Europe Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 61. China Nervous System Medications Sales Volume, 2018-2029, (K Units)
Figure 62. By Company, China Nervous System Medications Market Share, 2022
Figure 63. By Type, China Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 64. By Application, China Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 65. Japan Nervous System Medications Sales Volume, 2018-2029, (K Units)
Figure 66. By Company, Japan Nervous System Medications Market Share, 2022
Figure 67. By Type, Japan Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 68. By Application, Japan Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 69. South Korea Nervous System Medications Sales Volume, 2018-2029, (K Units)
Figure 70. By Company, South Korea Nervous System Medications Market Share, 2022
Figure 71. By Type, South Korea Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 72. By Application, South Korea Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 73. Southeast Asia Nervous System Medications Sales Volume, 2018-2029, (K Units)
Figure 74. By Company, Southeast Asia Nervous System Medications Market Share, 2022
Figure 75. By Type, Southeast Asia Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 76. By Application, Southeast Asia Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 77. India Nervous System Medications Sales Volume, 2018-2029, (K Units)
Figure 78. By Company, India Nervous System Medications Market Share, 2022
Figure 79. By Type, India Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 80. By Application, India Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 81. Middle East & Asia Nervous System Medications Sales Volume, 2018-2029, (K Units)
Figure 82. By Company, Middle East & Asia Nervous System Medications Market Share, 2022
Figure 83. By Type, Middle East & Asia Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 84. By Application, Middle East & Asia Nervous System Medications Sales Volume Market Share, 2022 VS 2029
Figure 85. Research Methodology
Figure 86. Breakdown of Primary Interviews
Figure 87. Bottom-up Approaches
Figure 88. Top-down Approaches
Research Methodology:
Nervous System Medications Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|